Alba Navarro
Overview
Explore the profile of Alba Navarro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
4176
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Grau M, Pol M, Montaner A, Mozas P, Nadeu F, Marquez-Lopez I, et al.
EJHaem
. 2024 Oct;
5(5):1014-1020.
PMID: 39415899
The genetic landscape underlying the transformation of splenic diffuse red pulp small B-cell lymphoma (SDRPL) is not well understood. The present study aimed to unravel the genomic alterations involved in...
2.
Grau M, Lopez C, Navarro A, Frigola G, Nadeu F, Clot G, et al.
Blood Adv
. 2023 Mar;
7(14):3695-3709.
PMID: 36995085
The genetic mechanisms associated with splenic marginal zone lymphoma (SMZL) transformation are not well defined. We studied 41 patients with SMZL that eventually underwent large B-cell lymphoma transformation. Tumor material...
3.
Mozas P, Lopez C, Grau M, Nadeu F, Clot G, Valle S, et al.
Hematol Oncol
. 2023 Mar;
41(4):631-643.
PMID: 36994552
While some follicular lymphoma (FL) patients do not require treatment or experience prolonged responses, others relapse early, and little is known about genetic alterations specific to patients with a particular...
4.
de la Hoz A, Navarro A, Avino A, Eritja R, Gargallo R
RSC Adv
. 2022 Apr;
11(15):9029-9042.
PMID: 35423401
Silver nanoclusters (AgNCs) prepared by the reduction of silver ions in the presence of DNA oligonucleotides have attracted great interest as potential diagnostic tools for their tunable and high fluorescent...
5.
Soleimani A, Navarro A, Liu D, Herman S, Chuang S, Slavutsky I, et al.
Leuk Lymphoma
. 2021 Nov;
63(4):911-917.
PMID: 34781807
Conventionally, mantle cell lymphoma (MCL) is an aggressive CD5-positive B-cell malignancy with poor prognosis and limited survival. However, a small subset of patients presents with indolent disease and can be...
6.
Bastidas-Mora G, Bea S, Navarro A, Gine E, Costa D, Delgado J, et al.
Br J Haematol
. 2021 Sep;
196(1):146-155.
PMID: 34519021
We describe 36 patients with splenic marginal zone lymphoma (SMZL) with transformation (SMZL-T), including 15 from a series of 84 patients with SMZL diagnosed at the Hospital Clinic of Barcelona...
7.
Balsas P, Veloza L, Clot G, Sureda-Gomez M, Rodriguez M, Masaoutis C, et al.
Blood
. 2021 Jun;
138(22):2202-2215.
PMID: 34189576
Mantle cell lymphoma (MCL) is a mature B-cell neoplasm with a heterogeneous clinical and biological behavior. SOX11 oncogenic expression contributes to the aggressiveness of these tumors by different mechanisms, including...
8.
Nadeu F, Royo R, Clot G, Duran-Ferrer M, Navarro A, Martin S, et al.
Blood
. 2020 Nov;
137(21):2935-2946.
PMID: 33211804
B-cell receptor (BCR) signaling is crucial for chronic lymphocytic leukemia (CLL) biology. IGLV3-21-expressing B cells may acquire a single point mutation (R110) that triggers autonomous BCR signaling, conferring aggressive behavior....
9.
Chronic lymphocytic leukaemia and prolymphocytic leukaemia. Two coins or two sides of the same coin?
Magnano L, Navarro A, Lopez-Guerra M, Clot G, Bea S, Bastidas G, et al.
Haematologica
. 2020 Oct;
105(9):e484.
PMID: 33054069
No abstract available.
10.
Demajo S, Albero R, Clot G, Castellano G, Navarro A, Capdevila C, et al.
Clin Cancer Res
. 2020 Oct;
27(1):213-225.
PMID: 33046520
Purpose: Mantle cell lymphoma (MCL) is characterized by the t(11;14)(q13;q32) translocation leading to cyclin D1 overexpression. Cyclin D1 is a major cell-cycle regulator and also regulates transcription, but the impact...